top of page

Press Releases

Life Seal Vascular Awarded $1.25M NSF SBIR Phase II Grant to Advance Cygnum Device Toward FDA Clinical Trials

Life Seal Vascular Announces Initial Implants of the Cygnum Aneurysm Sac Management Device in Japan

Life Seal Vascular Announces Enrollment of First Two Patients in the ASCEND FIH Study

Life Seal Vascular Inc. Appoints Dr. Matt Thompson as Chief Executive Officer

Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology

Life Seal Vascular Selected to Be in Dragon’s Den at Upcoming 45th Charing Cross Symposium.

News & Events

2026

Life Seal Vascular awarded NSF SBIR Phase II grant to advance Cygnum to FDA Clinical Trials

2025

First two patients treated in ASCEND first-in-human study using Cygnum aneurysm sac management device (Vascular News)

2024

Life Seal Vascular Receives NSF SBIR Grant for Aneurysm Sac Sealing Technology for EVAR (EVToday)

Life Seal Vascular awarded NSF SBIR grant to advance sac management technology for EVAR (Vascular News)

2023

Charing Cross 2023 Full programme

bottom of page